Jianmin Wang

5.2k total citations · 1 hit paper
141 papers, 2.7k citations indexed

About

Jianmin Wang is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Jianmin Wang has authored 141 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Hematology, 38 papers in Oncology and 33 papers in Molecular Biology. Recurrent topics in Jianmin Wang's work include Acute Myeloid Leukemia Research (43 papers), Hematopoietic Stem Cell Transplantation (42 papers) and Acute Lymphoblastic Leukemia research (16 papers). Jianmin Wang is often cited by papers focused on Acute Myeloid Leukemia Research (43 papers), Hematopoietic Stem Cell Transplantation (42 papers) and Acute Lymphoblastic Leukemia research (16 papers). Jianmin Wang collaborates with scholars based in China, United States and Switzerland. Jianmin Wang's co-authors include Shuqing Lü, Jianmin Yang, Xiao‐Jun Huang, Xiaoxia Hu, He Huang, Qifa Liu, Lan‐Ping Xu, Ming Jiang, Hui Cheng and Jing Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Jianmin Wang

134 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update

2021 150 citations Jing Chen, Mingzhe Han et al. profile →

Peers

Countries citing papers authored by Jianmin Wang

Since Specialization

Citations

This map shows the geographic impact of Jianmin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianmin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianmin Wang more than expected).

Fields of papers citing papers by Jianmin Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianmin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianmin Wang. The network helps show where Jianmin Wang may publish in the future.

Co-authorship network of co-authors of Jianmin Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jianmin Wang. A scholar is included among the top collaborators of Jianmin Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianmin Wang. Jianmin Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Droplet digital PCR: An effective method for monitoring and prognostic evaluation of minimal residual disease in JMML 2024 ·British Journal of Haematology ·(unknown), Yu–Chen Lin, Xia Qin, Miao Yan, (unknown), (unknown), Jianmin Wang, Xiaohang Huang, (unknown), (unknown), Jing Chen	0
2	Transcriptomic and metabolomic data of goat ovarian and uterine tissues during sexual maturation 2024 ·Scientific Data ·Yanyan Wang, Jianmin Wang, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Tianle Chao	5
3	Epstein-Barr Virus Reactivation and Post-Transplant Lymphoproliferative Disorders after Allo-HSCT in the Era of Letermovir for Cytomegalovirus Prophylaxis 2024 ·Blood ·(unknown), Jing Zhou, (unknown), (unknown), (unknown), Luxiang Wang, (unknown), Jiayu Huang, Zilu Zhang, Yanmin Zhao, Yang Cao, Jianmin Wang, Xiaoxia Hu	1
4	New insights into the clinical characteristics of SETD2‐mutated acute myeloid leukaemia 2023 ·British Journal of Haematology ·Xiang Zhang, Ziwei Wang, (unknown), Lixia Liu, (unknown), (unknown), Min Yang, Yinjun Lou, Gusheng Tang, Liping Mao, (unknown), Juying Wei, Wenyuan Mai, Haitao Meng, Jianmin Yang, Hongyan Tong, Jianmin Wang, Wenjuan Yu, Xiong Ni, Jie Jin	2
5	The benefit of chronic graft-versus-host disease in patients with acute myeloid leukemia relapsed after allogeneic stem cell transplantation 2019 ·Annals of Hematology ·Ziwei Wang, (unknown), Weiping Zhang, Wei Tang, Xianmin Song, Xiaoxia Hu, Xiong Ni, Huiying Qiu, Jianmin Yang, Jiong Hu, Jianmin Wang	7
6	Allogeneic hematopoietic stem cells transplantation improves the survival of intermediate-risk acute myeloid leukemia patients aged less than 60 years 2019 ·Annals of Hematology ·Ying Zhang, Yimin Zhang, Qi Chen, Gusheng Tang, Weiping Zhang, Jianmin Yang, Jianmin Wang, Xiaoxia Hu	17
7	Four-year follow-up of patients with imatinib-resistant or intolerant chronic myeloid leukemia receiving dasatinib: efficacy and safety 2018 ·Frontiers of Medicine ·Xiao‐Jun Huang, Qian Jiang, Jianda Hu, Jianyong Li, Jie Jin, Fan‐Yi Meng, Zhixiang Shen, Ting Liu, Depei Wu, Jianmin Wang, Jianxiang Wang	7
8	The long-term outcome of reduced-intensity allogeneic stem cell transplantation from a matched related or unrelated donor, or haploidentical family donor in patients with leukemia: a retrospective analysis of data from the China RIC Cooperative Group 2016 ·Annals of Hematology ·Chang‐Lin Yu, (unknown), Zhenhua Qiao, Jianmin Wang, (unknown), Yingmin Liang, Depei Wu, Baoan Chen, (unknown), (unknown), Wan-Jun Sun, (unknown), Mei Guo, Jian‐Hui Qiao, Qi‐Yun Sun, Kai‐Xun Hu, Yajing Huang, (unknown), Xiao‐Jun Huang, (unknown)	8
9	Epidemiology and treatment of invasive fungal diseases in patients with multiple myeloma: findings from a multicenter prospective study from China 2015 ·Tumor Biology ·Junru Liu, He Huang, Yan Li, Lin Liu, Jianyong Li, Zhuogang Liu, Jin Lu, Jian Ouyang, Yongping Song, Daobin Zhou, Hanyun Ren, Jun Ma, Chun Wang, Li Yu, Jin Zhou, Jianmin Wang, Yang Xiao, Xiao‐Jun Huang, Juan Li	9
10	Randomized Controlled Trials in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis 2014 ·Clinical Lymphoma Myeloma & Leukemia ·(unknown), Peter C. Trask, Jianmin Wang, Robert Olivares, Shahnaz Khan, Adeline Abbé, Ann Colosia, Annete Njue, Beth Sherrill, Rodrigo Ruiz‐Soto, James A. Kaye, Mehdi Hamadani	1
11	HBsAg is an independent prognostic factor in diffuse large B cell lymphoma patients in rituximab era: result from a multicenter retrospective analysis in China 2014 ·Medical Oncology ·Zheng Wei, Shanhua Zou, Feng Li, (unknown), Junmin Li, Jianmin Wang, Chun Wang, Fangyuan Chen, Junning Cao, Yunfeng Cheng	17
12	Synergetic Cooperation of microRNAs with Transcription Factors in iPS Cell Generation 2012 ·PLoS ONE ·(unknown), Guiying Wang, Chenqi Lu, Xudong Guo, (unknown), Jiuhong Kang, Jianmin Wang	22
13	Central nervous system involvement in adult patients with diffuse large B-cell lymphoma: Influence of rituximab 2012 ·Oncology Letters ·Bing Cao, Xiaoyan Zhou, Dongmei Ji, Junning Cao, Ye Guo, Qunling Zhang, Xianghua Wu, Junmin Li, Jianmin Wang, Fangyuan Chen, Chun Wang, Shanhua Zou, Xiaonan Hong	3
14	Value of circulating galactomannan screening for early diagnosis of invasive aspergillosis in hematological patients 2011 ·Lili Li, Jianmin Wang, Weiping Zhang, (unknown), Hui Cheng, Jianmin Yang, Xianmin Song, Li Chen, (unknown)	1
15	Predictors of Nipple–Areolar Complex Involvement by Breast Carcinoma: Histopathologic Analysis of 787 Consecutive Therapeutic Mastectomy Specimens 2011 ·Annals of Surgical Oncology ·Jianli Wang, Xiuli Xiao, Jianmin Wang, (unknown), Laurie Baxter, Kristin A. Skinner, David G. Hicks, Steven I. Hajdu, Ping Tang	41
16	Bortezomib attenuates acute graft-vs.-host disease through interfering with host immature dendritic cells 2011 ·Experimental Hematology ·Tao Yi, Weiwei Zhang, Yuan Fang, Dan Yang, Liping Wang, Hong Zhou, Jianmin Wang	10
17	Valganciclovir for pre-emptive therapy of cytomegalovirus viraemia after hematopoietic stem cell transplantation: a prospective multi-center trial. 2010 ·PubMed ·Kai‐Yan Liu, Yu Wang, Mingzhe Han, (unknown), Hu Chen, Qifa Liu, Jianmin Wang, Ting Liu, Yongping Song, Jun Ma, Depei Wu, Ping Zou, Xiao‐Jun Huang	7
18	Surgical treatment of unstable pelvic injury with displaced sacral fractures. 2009 ·Zhonghua guke zazhi ·Jian Jia, Jianmin Wang, Yang He	1
19	SAR and factor IXa crystal structure of a dual inhibitor of factors IXa and Xa 2004 ·Bioorganic & Medicinal Chemistry Letters ·Joanne M. Smallheer, Richard Alexander, Jianmin Wang, Shuaige Wang, (unknown), Karen A. Rossi, Angela Smallwood, Frank Barbera, Debra Burdick, Joseph M. Luettgen, Robert M. Knabb, Ruth R. Wexler, Prabhakar K. Jadhav	30
20	Clinical Protocol of Human Gene Transfer for Hemophilia B. Fudan University, Shanghai, China 1992 ·Human Gene Therapy ·(unknown), (unknown), Jiemin Zhou, (unknown), Yiping Hu, (unknown), (unknown), Bing Zheng, (unknown), (unknown), Peilin Meng, (unknown), Jianmin Wang	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact